Phase II study of alemtuzumab in combination with pentostatin in patients with T-cell neoplasms.
Ravandi F; Aribi A; O'Brien S; Faderl S; Jones D; Ferrajoli A; Huang X; York S; Pierce S; Wierda W; Kontoyiannis D; Verstovsek S; Pro B; Fayad L; Keating M; Kantarjian H; Journal Of Clinical Oncology: Official Journal Of The American Society Of Clinical Oncology, 2009, vol. 27, issue 32, p 5425, ISSN 15277755. ISBN 15277755.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef